Philippe Tanière
Queen Elizabeth Hospital Birmingham(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Tracking the Evolution of Non–Small-Cell Lung Cancer(2017)2,382 cited
- → TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers(2005)271 cited
- → PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains(2013)245 cited
- → DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours(2010)190 cited
- Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.(1998)
- → KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer(2017)164 cited
- → Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation